Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
325.60    -5.00 (-1.51%)
Bid:
325.20
Ask:
325.80
Spread: 0.60 (0.185%)
Market Cap: £1.73b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Response to Press Speculation

3 Aug 2020 07:00

RNS Number : 8453U
Hammerson PLC
03 August 2020
 

3 August 2020

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EC NO. 596/2014) ("MAR")

 

Hammerson plc

 

Response to Press Speculation

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

Hammerson plc (the 'Company') notes recent press speculation.

 

The Company confirms that it is in advanced discussions on the terms of a possible disposal of its 50% interest in VIA Outlets to its joint venture partner APG. It is also considering a possible equity raise by way of a rights issue.

 

The Company continues to take pro-active measures relating to the management of its cost base and cash-flow and in recent weeks it secured approval for the issuance of up to £300m under the Covid Corporate Finance Facility (CCFF) from the Bank of England. Following the reopening of its flagship destinations across Europe, footfall and sales continue to improve and Q3 rent collection in the UK (excluding monthly payments and deferrals) has increased to over 30%.

 

The Company will provide a further update in due course, if appropriate.

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

ENDS

 

This announcement is for information purposes only and shall not constitute or form part of any offer to issue or sell, or the solicitation of any offer to purchase, subscribe for or otherwise acquire, any securities of the Company in the United States (including its territories and possessions, any state of the United States and the District of Columbia) (the "United States" or "US") or any other jurisdiction. No public offering of the Securities is being made in any such jurisdiction. The securities referred to herein (the "Securities") have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States, and accordingly may not be offered, sold, resold, pledged, taken up, exercised, renounced, delivered, distributed or transferred directly or indirectly, into or within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any relevant state or other jurisdiction of the United States. No public offering of the Securities has been or will be made in the United States.

 

For further information:

 

Investor Contact

Josh Warren, Hammerson, Head of Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

 

Press Contacts

Hammerson

Catrin Sharp, Head of Corporate Communications

Tel: +44 20 7887 1063

catrin.sharp@hammerson.com

 

FTI Consulting (for Hammerson)

John Waples/ Dido Laurimore

Tel: +44 20 3727 1000/ 0780 1654424

dido.laurimore@fticonsulting.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RSPKKDBNOBKDAFK
Date   Source Headline
27th Jul 20234:30 pmRNSInterim Dividend Record Date Correction
27th Jul 20237:01 amRNSDividend Declaration
27th Jul 20237:00 amRNSHalf-year Report
5th Jul 20237:00 amRNSNotice of Results & IASB Accounting Interpretation
22nd Jun 202311:30 amRNSHolding(s) in Company
22nd Jun 20237:00 amRNSHolding(s) in Company
14th Jun 20239:30 amRNSHolding(s) in Company
12th Jun 20231:15 pmRNSHolding(s) in Company
31st May 20239:00 amRNSBlock listing Interim Review
30th May 202311:30 amRNSHolding(s) in Company
17th May 20239:00 amRNSDirector/PDMR Shareholding
4th May 20234:15 pmRNSResult of AGM
28th Apr 20234:15 pmRNSDirector/PDMR Shareholding
26th Apr 20233:30 pmRNSHolding(s) in Company
25th Apr 20237:00 amRNSPre AGM trading update
17th Apr 20234:00 pmRNSHolding(s) in Company
14th Apr 20239:00 amRNSHolding(s) in Company
13th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:00 amRNSAnnual Report and Notice of Annual General Meeting
3rd Apr 20237:00 amRNSDisposal
21st Mar 20235:15 pmRNSDirector/PDMR Shareholding
10th Mar 202311:45 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSFinal Results
6th Mar 20233:30 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSIASB Accounting Interpretation
16th Jan 20233:00 pmRNSNotice of Results and Registered Office Change
30th Nov 202210:00 amRNSBlock listing Interim Review
23rd Nov 202212:45 pmRNSShare capital reduction confirmation
22nd Nov 202212:30 pmRNSHolding(s) in Company
10th Nov 20228:00 amRNSDirector/PDMR Shareholding
8th Nov 20223:45 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSQ3 trading, operational and rent collection update
3rd Nov 20227:43 amRNSTotal Voting Rights
3rd Nov 20227:00 amRNS2023 EUR500,000,000 1.750 per cent Bond Redemption
1st Nov 20229:45 amRNSInterim Dividend and Enhanced Scrip Alternative
25th Oct 20222:30 pmRNSResult of General Meeting
19th Oct 202210:45 amRNSBoard Committee Appointment
12th Oct 20227:00 amRNSDirectorate Change
6th Oct 20224:00 pmRNSHolding(s) in Company
6th Oct 202210:00 amRNSCash Fractions for the Enhanced Scrip Dividend
30th Sep 20224:30 pmRNSHolding(s) in Company
28th Sep 202210:00 amRNSCircular, Notice of Meeting and Form of Proxy
27th Sep 20229:30 amRNSCurrency Conversion & Scrip Reference Share Price
14th Sep 20224:00 pmRNSInterim 2022 Dividend Expected Timetable of Events
18th Aug 202212:15 pmRNSHolding(s) in Company
28th Jul 20227:01 amRNSDividend Declaration
28th Jul 20227:00 amRNSHalf-year Report
14th Jul 202212:15 pmRNSDirector/PDMR Shareholding
11th Jul 20221:00 pmRNSDirector/PDMR Shareholding
28th Jun 202210:45 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.